Literature DB >> 21945973

Predicting healthcare utilization using a pharmacy-based metric with the WHO's Anatomic Therapeutic Chemical algorithm.

Raymond N Kuo1, Yaa-Hui Dong, Jen-Pei Liu, Chia-Hsuin Chang, Wen-Yi Shau, Mei-Shu Lai.   

Abstract

BACKGROUND: Automated pharmacy claim data have been used for risk adjustment on health care utilization. However, most published pharmacy-based morbidity measures incorporate a coding algorithm that requires the medication data to be coded using the US National Drug Codes or the American Hospital Formulary Service drug codes, making studies conducted outside the US operationally cumbersome.
OBJECTIVE: This study aimed to verify that the pharmacy-based metric with the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) algorithm can be used to explain the variations in health care utilization. RESEARCH
DESIGN: The Longitudinal Health Insurance Database of Taiwan's National Health Insurance enrollees was used in this study. We chose 2006 as the baseline year to predict the total cost, medication cost, and the number of outpatient visits in 2007. The pharmacy-based metric with 32 classes of chronic conditions was modified from a revised version of the Chronic Disease Score.
RESULTS: The ordinary least squares (OLS) model and log-transformed OLS model adjusted for the pharmacy-based metric had a better R in concurrently predicting total cost compared with the model adjusted for Deyo's Charlson Comorbidity Index and Elixhauser's Index. The pharmacy-based metric models also provided a superior performance in predicting medication cost and number of outpatient visits. For prospectively predicting health care utilization, the pharmacy-based metric models also performed better than the models adjusted by the diagnosis-based indices.
CONCLUSIONS: The pharmacy-based metric with the WHO ATC algorithm and the matching ATC codes were tested and found to be valid for explaining the variation in health care utilization.

Entities:  

Mesh:

Year:  2011        PMID: 21945973     DOI: 10.1097/MLR.0b013e31822ebe11

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  29 in total

1.  The impact of physician-level drug budgets on prescribing behavior.

Authors:  Katharina Elisabeth Fischer; Taika Koch; Karel Kostev; Tom Stargardt
Journal:  Eur J Health Econ       Date:  2017-02-13

2.  Supervised Learning Methods for Predicting Healthcare Costs: Systematic Literature Review and Empirical Evaluation.

Authors:  Mohammad Amin Morid; Kensaku Kawamoto; Travis Ault; Josette Dorius; Samir Abdelrahman
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

3.  The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective.

Authors:  Simon Frey; Tom Stargardt; Udo Schneider; Jonas Schreyögg
Journal:  Pharmacoeconomics       Date:  2019-08       Impact factor: 4.981

4.  Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.

Authors:  Jun Sung Hong; Eun-Jeong Yoon; Hyukmin Lee; Seok Hoon Jeong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

5.  Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study.

Authors:  Kristine Kreis; Dirk Horenkamp-Sonntag; Udo Schneider; Jan Zeidler; Gerd Glaeske; Lothar Weissbach
Journal:  Pharmacoecon Open       Date:  2021-06

6.  Predictive risk modelling in the Spanish population: a cross-sectional study.

Authors:  Juan F Orueta; Roberto Nuño-Solinis; Maider Mateos; Itziar Vergara; Gonzalo Grandes; Santiago Esnaola
Journal:  BMC Health Serv Res       Date:  2013-07-09       Impact factor: 2.655

7.  Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications.

Authors:  Carola A Huber; Thomas D Szucs; Roland Rapold; Oliver Reich
Journal:  BMC Public Health       Date:  2013-10-30       Impact factor: 3.295

8.  Comorbidity in patients with branch retinal vein occlusion: case-control study.

Authors:  Mette Bertelsen; Allan Linneberg; Thomas Rosenberg; Nynne Christoffersen; Henrik Vorum; Else Gade; Michael Larsen
Journal:  BMJ       Date:  2012-11-30

9.  The influence of socio-economic status and multimorbidity patterns on healthcare costs: a six-year follow-up under a universal healthcare system.

Authors:  Raymond N Kuo; Mei-Shu Lai
Journal:  Int J Equity Health       Date:  2013-08-20

10.  Comparing potentially avoidable hospitalization rates related to ambulatory care sensitive conditions in Switzerland: the need to refine the definition of health conditions and to adjust for population health status.

Authors:  Yves Eggli; Béatrice Desquins; Erol Seker; Patricia Halfon
Journal:  BMC Health Serv Res       Date:  2014-01-20       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.